Interaction of cytochrome P450 3A4 with cannabinoids and the drug darifenacin
Abstract Cytochrome P450 3A4 (CYP3A4) is an important drug-metabolizing enzyme whose substrate binding mechanism remains incompletely understood because of insufficient…
Abstract Cytochrome P450 3A4 (CYP3A4) is an important drug-metabolizing enzyme whose substrate binding mechanism remains incompletely understood because of insufficient…
Abstract The use of cannabinoids has a history spanning thousands of years, and their pharmacological and toxicological properties, particularly those…
Abstract Cannabidiol (CBD) is one of the major phytochemical constituents of cannabis, Cannabis sativa, widely recognized for its therapeutic potential.…
Abstract Oxysterols and bile acids are interconnected bioactive lipids playing pivotal roles in diverse physiological and pathological processes. For this…
Abstract Cannabis sativa is an economically important crop, yet weed management remains a significant challenge due to limited herbicide options.…
Abstract Aim: Our objective was to systematically assess the prevalence and clinical features of adverse events related to interactions between…
Abstract Clinical practice entails a translation of research that assists in the use of scientific data and therapeutic evidence for…
Abstract Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease with multiple genetic and a variety of environmental risk factors.…
Abstract Cannabidiol (CBD) is a biologically active, non-psychotropic component of Cannabis sativa whose popularity has grown exponentially in recent years.…
Abstract AB-FUBINACA, a synthetic indazole carboxamide cannabinoid, has been used worldwide as a new psychoactive substance. Because drug abusers take…